Monica Macedo Bastos

Monica Macedo Bastos

Fundação Oswaldo Cruz - Rio de Janeiro / Brazil
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4387926
Oswaldo Cruz Foundation
person_outline Monica Macedo Bastos's MOST POPULAR ARTICLES
1-) Novel 1,2,3-Triazole Derivatives for Use against Mycobacterium tuberculosis H37Rv (ATCC 27294) StrainN Boechat, VF Ferreira, SB Ferreira, MLG Ferreira, FC da Silva, ...Journal of Medicinal Chemistry 54 (17), 5988-5999, 20112742011
2-) The clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationCQ Sacramento, GR de Melo, CS de Freitas, N Rocha, LVB Hoelz, ...Scientific reports 7 (1), 1-12, 20171802017
3-) Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivoCS de Freitas, LM Higa, CQ Sacramento, AC Ferreira, PA Reis, ...PLoS neglected tropical diseases 13 (1), e0007072, 2019802019
4-) Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus ReplicationAC Ferreira, PA Reis, CS de Freitas, CQ Sacramento, L Villas Bôas Hoelz, ...Antimicrobial agents and chemotherapy 63 (2), 10.1128/aac. 01389-18, 2019972019
5-) In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19CQ Sacramento, N Fintelman-Rodrigues, JR Temerozo, APD Da Silva, ...Journal of Antimicrobial Chemotherapy 76 (7), 1874-1885, 2021732021